PDS Biotechnology (PDSB) Tops Q2 EPS by 1c

PDS Biotechnology (NASDAQ: PDSB) reported Q2 EPS of ($0.21), $0.01 better than the analyst estimate of ($0.22).

For earnings history and earnings-related data on PDS Biotechnology (PDSB) click here.

You May Also Be Interested In

• Virtu Financial posts Q2 2026 preliminary results, seeks $400M loan
• PTC launches Onshape Labs early-access AI program for engineers
• Goldman Sachs on Bank of America (BAC): 'We view these results as better than expected'